Table 1 PDXs from which TILS were obtained by culture
From: Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Case ID | Passages | In vivo days | In vitro days | CD8+ (%) | CD4+ (%) | CD19+ (%) |
|---|---|---|---|---|---|---|
1 | F1 | 292 | 14 | 99.1 | 0.5 | 0.9 |
4 | F1 | 90 | 10 | 72.1 | 1.6 | 0 |
5 | F1 | 128 | 13 | 50.3 | 4.6 | 0 |
13 | F1 | 98 | 10 | 76.1 | 20 | 0.7 |
2 | F1 | 133 | 10 | 1.9 | 0 | 95.8 |
11 | F1 | 63 | 10 | 12.3 | 0.2 | 87.1 |
10 | F1 | 69 | 7 | 8.7 | 26.9 | 77.6 |
19 | F2 | 84 | 22 | 99.2 | 0 | 0 |
16 | F2 | 72 | 14 | 23.7 | 70.2 | 0 |